Evaluation of an Anti-Shivering Protocol Cardiac Arrest
NCT ID: NCT05264246
Last Updated: 2024-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
165 participants
OBSERVATIONAL
2021-09-15
2024-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest
NCT01413399
Pilot Community Clinical Study of Hypothermia in Cardiac Arrest
NCT00329563
Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest
NCT00391469
Reperfusion With Cooling in Cerebral Acute Ischemia II
NCT01728649
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
NCT04217551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of cardiac arrest
* Initiation of TTM via Arctic SunĀ® device
Exclusion Criteria
* Receiving NMBs for an indication other than TTM
* Early termination of TTM (less than 24 hours)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Methodist Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamara Reiter, PharmD
Role: PRINCIPAL_INVESTIGATOR
Methodist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Methodist Dallas Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
042.PHA.2021.D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.